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Executive summary 
 
Background 
There is international recognition that cancer in young people is on the rise and 
that improvements in outcomes of young people lag well behind the advances 
achieved for both children and older adults over the past thirty years. Cancer is 
the third leading cause of death in adolescents and young adults, however, little 
is known about how end of life unfolds for those who die of progressive disease. 
Objective 
This scoping review sought to locate and describe literature relating to end of life 
care for adolescents and young adults with cancer. 
Inclusion criteria 
Types of participants 
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We considered studies that focused on adolescents and young adults aged 10-24 
with advanced cancer at the end stage of life and those who care for them. 
Types of intervention(s)/ phenomena of interest 
We considered studies that focused on end of life care, including service 
provision, practices and interventions and the experiences and perceptions of 
adolescents and young adults with advanced cancer and their health 
professionals and family carers.   
Types of studies 
We included all quantitative and qualitative research designs 
Types of outcome 
The purpose of the review was to map existing literature on this topic and to 
identify what outcomes were being measured by current research.  
Search strategy 
A three-step search strategy was used in this review.  
Methodological quality 
This review is a scoping review to provide a broader picture of the existing 
literature on this topic. Hence, assessment of methodological quality was not 
performed to exclude studies based on quality scores. 
Data collection 
Data was extracted using extraction tools from the Joanna Briggs Institute Meta- 
Analysis of Statistics Assessment and Review Instruments (JBI-MAStARI) and 
the Joanna Briggs Institute Qualitative Assessment and Review Instrument (JBI-
QARI).   
Data synthesis 
The findings are presented in narrative form including tables and figures to aid in 
data presentation where appropriate. 
Results 
Twenty studies published in English were included in this review.  Research 
designs were mainly descriptive and retrospective using data from case notes or 
medical records (n=8) and focus groups (n=4). There was a single randomised 
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controlled trial, four cross sectional surveys, two prospective cohort studies and 
one that used data from three studies to develop guidelines. 
Conclusion 
Relatively little research was located relating to experiences and perceptions of 
adolescents and young adults and their carers in relation to decision making and 
advanced care planning. The main focus of the research was medical record 
review and interviews with bereaved parents. 
Implications for practice 
The overall focus on retrospective data and the heterogeneous and descriptive 
nature of the studies makes recommendations for practice limited. Encouraging 
adolescents and young adults to participate in decisions about their end of life 
care through the use of advance care planning documents, introduced at a 
suitable stage of their illness, appears to be an appropriate way forward. 
Implications for research 
Future research should focus specifically on adolescents and young adults at the 
end of life and consider both their perspective and that of their carers, 
particularly with regard to decision making. Research should also focus on 
factors influencing appropriate place of death. 
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Introduction 
Background 
This review will scope the literature relating to the provision of end of life care in 
adolescents and young adults (AYA) with advanced cancer. It is estimated that 
there were around 173,000 cases of cancer diagnosed in adolescents and young 
adults (15-24 years) worldwide in 2008.1 In the same time period for the 27 
countries of the European Union there were 14,700 new cases.1 In the UK in 
2008-2010, an average of 2,214 adolescents and young adults (15-24 years) 
were diagnosed with cancer.1 The incidence rates of all cancers for this 
population have been shown to be steadily increasing since the 1990s and 10-
40% of adolescents and young adults(15-24 years) diagnosed with cancer will 
develop incurable disease2 with an estimated 86,000 deaths worldwide being 
reported in 2008.1 In Europe this figure was estimated to be 2,500.1 In 2008-
2010, an average of 313 teenagers and young adults per year in the UK died 
from cancer.3  There is international recognition that not only is cancer in young 
people on the rise, but that improvements in outcomes of young people lag well 
behind advances achieved for both children and older adults in the past 30 
years.4 Cohen-Gogo et al (2011) noted that cancer is the third leading cause of 
death in adolescents and young adults.5 However, little is known about how end 
of life unfolds for those who die of progressive disease. 
 
Three interchangeable terms are often used to refer to end of life (EoL) care 
which have distinct but overlapping meanings; hospice, palliative care and EoL 
care.6  
Hospice 
Hospice is defined as “a program of care that supports the patients and family 
through the dying process and the surviving family members through 
bereavement”. 7 p.164 
Palliative Care 
The World Health Organisation defines palliative care as: “The active total care 
of patients whose disease is not responsive to curative treatment. Control of 
pain, of other symptoms and of psychological, social and physical problems is 
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paramount. The goal of palliative care is achievement of the best quality of life 
for patients and their families”. 8 p.11 
 
The National Comprehensive Cancer Network (NCCN) clinical practice guidelines 
for adolescent and young adult oncology recognise that palliative care is 
accepted as a treatment to control symptoms, and reduce environmental and 
physical suffering at any stage of a life threatening illness.9  
 
End of Life Care  
Grinyer and Barbarchild (2011) suggest that end of life care is used to describe 
the care that focuses on preparation for an anticipated death and should 
promote clear and culturally sensitive communication to help patients and their 
families understand the diagnosis, prognosis and treatment options available, 
including pain control and support systems for patients and their families which 
includes psychological and spiritual care.10 
 
Similarly, the goals of EoL care are described as ‘preventing and managing 
symptoms and assisting the dying child or adolescent and his family members in 
finding comfort and meaning during this phase of care’.6 p.126. 
 
Whilst a diagnosis of cancer may be considered traumatic and life-changing at 
any age, in adolescents and young adults it may have extra significance as it 
occurs during a critical and unique phase of the human life course.11  The threats 
associated with advanced cancer in young people can be expected to provoke 
strong emotions and prove challenging for all involved.  
 
The essential feature of effective and appropriate EoL11 care is a relevant 
concern for those close to the patient, as well as those providing the service. 
Palliative care for adolescents needs to take into account the normal physical 
and psychological changes associated with adolescence, including attainment of 
independence, social skills, peer acceptance and self-image building.2  
 
In the article entitled “Improving Outcomes Guidance for Children and Young 
People” the age range of adolescents is defined as 15-24 years,12 however some 
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studies describe children from the age of 10 years as adolescents.13,14  Schrijvers 
and Meijnders (2006) further define adolescence by the appearance of 
secondary sex characteristics and terminating with the cessation of somatic 
growth.2  The World Health Organisation (2001) refers to individuals aged 10-19 
years as adolescents and those aged 15-24 years as youth.15  The NCCN defined 
an AYA as an individual aged 15-19 years at initial cancer diagnosis.  Thomas et 
al (2006) note that in contrast to physical maturation, psychosocial maturation is 
highly variable but involves an increasing capacity for abstract thought enabling 
the realisation of concepts that lie outside of one’s immediate experience such as 
death.4  For the purpose of this scoping review an adolescent and young adult 
reflects this variation in the literature and will be defined as between 10 to 24 
years.  
 
An overview of research into EoL care for paediatric patients with cancer noted 
that substantial research gaps exist relating to the experiences of dying children 
and adolescents and their bereaved survivors. The reviewers commented that 
the studies had been conducted using retrospective, descriptive or pilot 
intervention designs and conducted in single institution settings with small 
numbers of patients and omitting the perspective of the dying child.6 The 
participation rate of adolescents and young adults in Canada and the United 
States has been shown to be considerably lower than children and older adults, 
with many aspects of the adolescents and young adults’ population being 
understudied.16 A search of the Cochrane Database of Systematic Reviews, 
DARE, Joanna Briggs Institute (JBI) Library of Systematic Reviews and PubMed 
clinical queries identified that there were no existing systematic reviews 
addressing this topic, and only one related systematic review protocol, which 
focused on children, as opposed to adolescents and young adults.17  
 
However, there has been a rapid expansion in interest around the needs of 
young people with cancer in recent years. Multi-professional groups such as 
Teenagers and Young Adults with Cancer (TYAC) (www.tyac.org.uk) have 
lobbied for greater awareness and members of the project team have been 
closely involved in this group and its activities. There has also been a rise in 
publications on the needs of this age group, including concerns about the lack of 
clinical trials,18 the impact of adolescents and young adult cancer on parents and 
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families,19 the place of death of young adults with cancer20 and the nature of 
specialist teenage cancer units.21  Despite the unique nature of this age group’s 
EoL support needs, there is a lack of empirical evidence currently available which 
supports the need for this scoping review and further research. This scoping 
review will be informed by the work of Arksey and O’Malley (2005) who suggest 
a six stage methodological framework for conducting scoping reviews which 
includes: identifying the research question, searching for relevant studies, 
selecting studies, charting data, collating, summarising and reporting the 
results, and consulting with stakeholders to inform or validate study findings.22 
 
The objectives, inclusion criteria and methods of analysis for this review were 
specified in advance and documented in a protocol.† 
Review question/objectives 
This scoping review sought to locate and describe literature relating to EoL care 
provision to adolescents and young adults with cancer. The specific areas of 
investigation included 
 
 End of life care service provision in adolescents and young adults with 
cancer during the EoL phase of care 
 Experiences and perceptions of adolescents and young adults with 
cancer during the EoL phase of care  
 Experiences and perceptions of the health professionals and family 
members involved in their care 
 Practices/interventions used with adolescents and young adults with 
cancer during the EoL phase of care 
Inclusion criteria 
Types of participants 
This scoping review considered all studies that focused on adolescents and 
young adults aged 10-24 with advanced cancer and their families at the end 
stage of life. Studies were also included where the adolescents and young people 
                                                 
† Edwards et al (2013)  Factors influencing the provision of End of Life care for 
adolescents and young adults with advanced cancer: a scoping review protocol JBI 
Database of Systematic Reviews & Implementation Reports 11(7) 386 - 399 
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were part of a larger sample of patients with advanced cancer but where it was 
possible to accurately identify data that was from adolescents and young people 
separately. End stage of life is described as any care or service provision that 
focuses on the preparation for a death that is anticipated.10 
 
Types of intervention(s)/phenomena of interest 
This review considered all research studies that specifically addressed: 
 End of life care service provision in adolescents and young adults with 
cancer during the End of life phase of care 
 Experiences and perceptions of adolescents and young adults with 
advanced cancer during the End of life phase of care 
 Experiences and perceptions of health professionals and family carers 
in relation to caring for adolescents and young adults with advanced 
cancer during the End of life phase of care 
 Practices/interventions used with adolescents and young adults with 
cancer during the End of life phase of care, for example pain control, 
psychological and spiritual care. 
Context 
This review considered studies wherever End of life care was provided for 
adolescents and young adults with cancer. This included, but was not exclusive 
to, hospitals, hospices, respite care homes, adolescents and young adults’ home 
settings. 
Types of studies 
This review considered both quantitative and qualitative studies. 
Quantitative 
This review considered both experimental and observational study design 
including randomised controlled trials, non-randomised controlled trials, quasi-
experimental, before and after studies, prospective and retrospective cohort 
studies; case control studies and analytical and descriptive cross-sectional 
studies. 
Qualitative 
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This review considered studies that focused on qualitative data including, but not 
limited to, designs such as phenomenology, grounded theory, ethnography, 
action research and feminist research. 
Types of Outcomes 
The intention in this scoping review was to map the literature and represent the 
range of outcomes investigated in this topic. As such the scoping review 
considered all outcomes for the following 
 
Primary Outcomes  
1. For the adolescents and young adults which could include;  
Control of pain and other symptoms 
Place of death 
Psychological, social issues and spiritual issues 
Impact of end of life care 
Decision making  
Secondary Outcomes  
2. For the family carer and health care professional which could include; 
Psychological, social issues and spiritual issues 
Impact of end of life care 
Preferences for where end of life care is provided 
Decision making  
Exclusion Criteria 
 End of life care for adults over 25 years.  
 End of life care for children under 10 years.  
 Care provided for adolescents and young adults with cancer that is not 
focused towards end of life care. 
 End of life care provided for adolescents and young adults for conditions 
other than cancer. 
Search strategy 
The search strategy aimed to find both published and unpublished studies over 
the last 15 years from 1998 to 2013. A three-step search strategy was used in 
this review.  
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Stage 1  
This stage involved an initial search of MEDLINE and CINAHL using preliminary 
keywords drawn from the natural language terms of the topic, followed by 
analysis of the text words contained in the title and abstract, and of the index 
terms used to describe articles.  
 
The preliminary keywords searched were; 
1. Adolescents 
2. Young adults 
3. Teenagers 
4. Palliative care 
5. End of life care 
6. Cancer 
Stage 2  
The text words contained in the title and abstract of relevant articles, along with 
the controlled language index terms used to describe the papers, were then 
analysed to develop keywords for stage two. A second extensive search was 
then undertaken of all keywords and index terms identified as relevant to the 
review across all included databases. The databases searched for published 
material included: CINAHL, MEDLINE, British Nursing Index, Cochrane Library, 
EMBASE, PsycINFO, PsycARTICLES, Web Of Knowledge, TRIP, ERIC, Scopus and 
The Joanna Briggs Institute (JBI) COnNECT+. The search terms included MeSH 
and ‘free text’ terms in combination and was adapted according to the particular 
database copy of the Medline search is provided as it represents the most 
complex and comprehensive of all strategies (Appendix 1)   
 
The sources searched for relevant unpublished material included: Open Grey 
(formerly SIGLE -System for Information on Grey Literature in Europe), 
contacting authors (Pamela Hinds, Ann Grinyer) and experts (Sheila Payne), and 
organisations (together for short lives, CLIC Sergeant and the International 
observatory on End of Life Care) active within the phenomenon of interest to 
attempt to identify further published, un-published and ongoing studies and 
Dissertation Abstracts International  
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Stage 3  
References from retrieved articles were then searched for additional studies for 
the final stage of the process. On the advice of lead researchers in the field the 
Journal of Palliative Medicine was hand-searched between 2012 and 2013 to 
ensure that any relevant papers that may not be indexed in the major databases 
were located. 
 
The search sought all published and unpublished studies. Only English language 
papers were included in this review due to the limited resources available. 
 
Reference software was used to manage the list of all the citations retrieved and 
all unnecessary duplications were removed. Articles searched were then 
assessed for relevance to the review based on the information provided in the 
title, abstract and descriptor/MESH terms by two independent reviewers.  Where 
any doubt existed, the full article was retrieved. The full article was retrieved for 
all studies that met the inclusion criteria of the review. A screening tool to aid 
this process was used (see Appendix 2). Based on full texts, two reviewers 
examined independently whether the studies conformed to the inclusion criteria.  
Disagreement was resolved by discussion with a third reviewer. Multiple articles 
by the same authors that reported findings from the  same study were linked 
together and the information was used for the decision concerning which studies 
were eligible for inclusion. Studies identified from reference list searches were 
assessed for relevance based on the study title. The full article was retrieved for 
all studies that met the inclusion criteria of the review 
Method of the review  
The review performed here is a focused scoping review to locate and describe 
existing literature in relation to EoL care provision for adolescent and young 
adults with cancer. Scoping reviews typically do not include a quality assessment 
of included studies.23,24 No attempt was made to formally assess the quality of 
the individual included papers, although an overall brief summary is provided.  
Data extraction 
Quantitative data was extracted from papers in the review using the 
standardised data extraction tools from JBI-MAStARI. Two reviewers extracted 
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data independently. Disagreement was resolved by discussion with a third 
reviewer.  The data extracted included specific details about the interventions, 
populations, study methods and outcomes of significance to the review question 
and specific objectives. Qualitative data was extracted from papers in the review 
using the standardised data extraction tool from JBI-QARI. The data extracted 
included specific details about the phenomena of interest, populations, study 
methods and outcomes of significance to the review question and specific 
objectives. This is in line with charting the data as outlined in stage four of 
Arksey and O’Malley’s framework.22  Primary authors were contacted for further 
information if further clarification of the data was required. 
Data synthesis 
As per a previous JBI scoping review23 the review findings are discussed in 
narrative form including tables. The approach described by Arksey and 
O’Malley22 was followed and an overview of all the included material is 
summarised in tables and charts which map the literature. Literature was 
tabulated using the following headings: research design, geographical location, 
year of publication, characteristics of study population and the research 
outcomes. 
Review results 
Description of studies 
The database searches yielded a total of 6917 citations after duplicates were 
removed. The titles and abstracts for these 6917 citations were screened and 
312 citations were considered for further detailed assessment of the full paper. 
yielding a total of 20 original citations for inclusion in this review, one of which 
was located through hand searching. A summary table which maps the literature 
is presented in Appendix 3.  
 
A flow chart showing the number of citations at each stage is detailed below 
(Figure 1).  
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Figure 1: Flow chart of study selection  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All references found in databases searches 
8762 
Screened by abstract and title 
6917 
Duplicates removed 
1845 
Excluded 
6605 
Detailed assessment based on full paper 
312 
Identified via hand 
searching and 
reference lists  
n=3 
Identified via grey 
literature 
n=1 
Citations included  
20 
Excluded 
296 (See Appendix 4) 
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Results 
Country of publication 
Included studies were published between 2000 and 2013. The studies were 
conducted in USA (8)12,13,24-28,30,34, France (2)5,25, Australia (2)26-28, Netherlands 
(1)29, Sweden (1)30, Germany (1)31, UK (3)20,32 and Canada (1)33.  One study was 
conducted in both the USA and Australia.29   
Age of sample 
Only one study referred specifically to the sample as adolescents.35  Two studies 
reported the age of the AYAs at diagnosis 26,30 and seven reported on age at 
death.20,25,29,31,33,34,36,37  Three studies presented both age at diagnosis and age at 
death.5,14,32  Two of the studies that followed AYAs prospectively through 
treatment at EoL reported the age of the sample at the time treatment 
commenced.13,27  A further five studies reported the age of the AYA at the time 
that the research was undertaken.28,38-41  
 
Ten studies were concerned with EoL issues for both children and 
adolescents13,26,27,29,31-34,35,37 and it was possible to separate out the results for 
the adolescents: 12-19 years33, 11-18 years31, 15-21 years35, 10-14 and 15-18 
years32 and for 13.2-21.3 years37, 7 and younger, 7 to 12 and 12 and over with 
a mean age of 10.9 (SD 4.9 years)29, 10-14, 15-19 and 20-24 years13, 15-24 
years34 and individuals aged 13.4, 16.4, 18.7, 17.6.27 
 
Seven papers were concerned solely with EoL issues for 
adolescents5,14,20,25,26,30,39. The reported age of the participants were 10-21 
years42, 14.2-24.2 years5, 11-24 years20, 15-25 years25, 15-21 years39,10-17 
years26, 9-15 and 16-25 years30, 18-28 years (Mean 20.3 years)38.  
Sample size 
The size of the sample varied widely from 4-1305,14,25-29,31,33,37-41 for studies 
conducted in a single institution. One multi-centre study included 432 
participants across 33 hospitals13 and for data collected from four population 
based epidemiological studies numbers in each study were 19530, 43232and 
199720, 1,76734 respectively. One survey undertaken by Jones et al 2006 was 
conducted on a sample of 131 Paediatric oncology social workers.35 
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Research design 
Five studies used a retrospective case note review to obtain their information: 
survey of pain and palliative care databases37; charts, medical records, 
outpatient clinic nursing phone logs, and social work files on each patient14; 
Medical and nurses chart analysis5; Medical record review13,26. Four studies were 
of a retrospective descriptive design and were undertaken using focus groups of 
bereaved parents between 3 and 11 years after an AYAs’ death33; questionnaires 
sent 1-3 years29 or 4-9 years30 after death, semi structured interviews with 
bereaved parents 2-6 years after  death.25  A further four were descriptive cross 
sectional surveys.28,35,38,40,41.  Three studies were retrospective descriptive 
epidemiological studies using death registration data from cancer 
registries20,32,34, two were prospective cohort studies27,31 one randomised 
controlled trial39 and one used data from three studies (one retrospective and 
two prospective descriptive) to develop guidelines for end of life decision making 
in pediatric oncology41. 
Period of data collection and EOL care 
The time frame over which data was collected is shown below and ranged from 1 
year to 10 years (see Table 1).  
Table 1: Time frame over which was data collected in years  
Author Years (n) 
Cohen-Gogo et al 20125 1 year 
De Graves and Aranda 201226 1 year 
Lyon et al 201339 1 year  
Anghelescu et al 201037 1.5 years 
Noyes and Irving 201127 3 years - 
Montel et al 200925 3 years  
Wiener et al 201238 3.5 years  
Janssen et al 200031 4 years  
Bell et al 201042 5 years 
Higginson and Thompson 200320 5 years 
Orsey et al 200913 5 years 
Surkan et al 200630 6 years 
Shah et al 201132 8 years 
NCIN 201134 9 years  
Cataudella and Zelcer 201233 10 years  
Theunissen et al 200729 10 years 
Hinds et al 200940 N/A 
Hinds et al 200141 N/A 
Hinds et al 200528 N/A 
Jones 200635 N/A 
N/A – not applicable  
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Only 5 of the studies defined the time period for EoL5,13,30,37,42, ranging from the 
last week of life5,13, last month of life30, last 3 months of life 37 or time from 
initial EoL discussion to death, categorised as 0-14 days / 15-30 days / 31-60 
days/ 61-179 days / 180-880 days.42  Two studies defined EoL as the start of 
palliative treatment and then recorded time until death occurred: 6 hours to 22 
days27, 1-26 months 31. Three studies looked at place of death only20,25,32 and 
EoL was not defined in 3 studies26,33,35. For the study by Theunissen et al 200729 
the only information given was for palliative care which was defined as a shift in 
the goal from cure to palliation but no actual time points were reported. Three 
studies looked at EoL decision making, within the previous 7 days28 or previous 
72 hours40 and was not defined by Hinds et al 200141 . A further two studies 
asked adolescents with cancer to consider decisions around advanced care 
planning at the EoL.38,39.  
 
Location of research 
The majority of research was conducted at a single site in a children’s hospital 
with the exception of Orsey et al and Hinds et al 200513,28 or data was extracted 
from tumour registries or death registrations (see Table 2). More specific 
hospital based locations were reported by Surkan et al 200630 (24% children’s 
oncology ward, 10% intensive care unit, 5% another ward, 3% adult ward) and 
Cohen-Gogo et al 20115 (44.4% Pediatric department 6% local hospital, adult 
palliative care unit 4.4%, intensive care unit 4.4%). 
 
Table 2: Location of research  
Noyes and Irving 201127 Royal Children’s Hospital – oncology Unit Queensland 
and Northern New South Wales 
Orsey et al 200913 Pediatric Health Information System database for 38 
children’s hospitals located throughout the USA 
Janssen et al 200031 Children’s Hospitals of Bonn, Dusseldorf and Wuppertal  
Hinds et al 200141 N/A 
Hinds et al 200940 St Jude Children’s Research Hospital in Memphis 
Hinds et al 200528 St Jude Children’s Research Hospital in Memphis 
Sydney Children’s Hospital In Sydney 
Surkan et al 200630 Swedish Cause of Death Register 
Theunissen et al 200729 Department of Pediatric Haematology/Oncology of the 
Radboud University Nijmegen Medical Centre  
Cataudella and Zelcer 201233 Patient tumour registry for south western Ontario 
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Higginson & Thompson 
200320 
Death registrations in England and Wales 
NCIN 201134 National Cancer Repository in England (excluding London 
and South East England) 
Shah et al 201132  National Registry of Childhood Tumours for England  
Anghelescu et al 201037 St Jude Children’s Research Hospital in Memphis 
Bell et al 201042 Midwestern tertiary care centre  
De Graves and Aranda 201226 Single tertiary paediatric centre 
Cohen-Gogo et al 20125 Pediatric and Adolescent Oncology Department at the 
Institut Gustave Roussy  
Montel et al 200925 Paediatric Oncology Department of a regional cancer 
centre  
Jones 200635 N/A 
Lyon et al 201339 Pediatric oncology program 
Wiener et al 201238 Pediatric Oncology Branch from the National Cancer 
Institute  
The analysis is presented with regard to the four objectives proposed for this 
review: EoL care service provision (n=8), Experiences and perceptions of AYAs 
(n=3), Experiences and perceptions of health care professionals and family 
members (n=7), Practices/interventions used with AYAs with cancer during the 
EoL phase of care (n=4). Studies in multiple categories are counted for each 
category in which they feature. 
1. EoL care service provision 
The studies that discussed care service provision focused primarily on place of 
death, this included investigation of a number of influencing factors. 
Place of Death 
The location of death varied according to the individual wishes and needs of the 
child and their family and was investigated in 8 studies.5,20, 25,26,30,32,34,42  
Table 3: Location of place of death for AYAs 
Country, Author, Age  Hospital Home  Hospice Other Missing 
USA  
Bell et al 201042 
10-21 years  
 
 
58% 
 
 
16% 
   
 
29% 
France  
Cohen-Gogo et al 20125 
14-26 years  
 
 
76.5% 
 
 
8.8 
  
 
4.4%* 
 
 
11.2% 
England and Wales 
Higginson and Thompson 2003 
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16-24 years  57.7% 30.4% 9.4% 2.4% 
England 
Shah et al 201132 
10-14 years 
15-19 years 
 
 
46% 
38% 
 
 
47% 
54% 
 
 
7% 
8% 
  
 
 
 
England (excluding London and 
South East England) 
NCIN 201134 
15-24 years  
 
 
 
52% 
 
 
 
32% 
 
 
 
13%a 
 
 
 
3%c 
 
France  
Montel et al 200925 
15-25 years  
 
 
90.5% 
    
Sweden  
Surkan et al 200630 
 
64% 
 
36% 
  
2%b 
 
Australia  
De Graves and Aranda 201226 
10-16 years 
 
 
45% 
 
 
55% 
   
a : hospice or specialist palliative care unit b: foreign country, c: care home or other place 
 
Four studies evaluated factors influencing place of death20,30,32,34.  The population 
based study by Surkan et al 200630 in Sweden investigated associations between 
a number of demographic variables and home as the place where the AYA was 
cared for during the last month and died. Dying at home was found to be 
strongly related to type of malignancy.  Specifically patients with leukaemia or 
lymphoma were much less likely to die at home and the authors suggest that 
this could be because they require blood products more frequently than AYAs 
with other types of malignancies. There were also strong significant associations 
between parents and AYAs' awareness about death (four specific variables) with 
death at home and care at home in the last month. The four variables were: 
 i) intellectually realising that their AYA would die (p<0.05); ii) emotionally 
realising that AYA would die (p=0.2), iii) parents who sensed that their AYA was 
aware of his/her own imminent death (p<0.01); iv) parents getting information 
that their AYAs’ illness was incurable a month or more before death (p<0.01).   
 
In the much larger population based studies of all cancer deaths in England and 
Wales during 1995 to 199920 and in England during 1999-2006; multivariate 
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analysis found that home death was less likely with increasing age (p<0.05)20, 
for young women (p<0.05)20, for patients with leukaemia or lymphoma rather 
than solid tumours (p<0.05) 20,32, more likely where access to local services 
(school, shops, general practitioner) was good (p<0.05)20 and those treated at a 
Childhood Cancer Research Group centre.32  Dying in hospital was more likely for 
those dying within six months of diagnosis and those from ethnic minorities or 
deprived backgrounds.32 
 
Data from the National Cancer Intelligence network explored patterns of place of 
death among children, teenagers and young adults with cancer in England who 
died during 2000-2009 (NCIN 2011).  It was found that death of patients with 
leukaemia or lymphoma was more likely to occur in hospital whereas the highest 
proportion dying in their own homes was for bone tumours.  For those aged 15-
24 years the proportion dying in a hospice or SPCU was higher for patients with 
melanoma and carcinoma.  There was no statistically significant variation in 
place of death by deprivation or Asian ethnic background for those aged 15-24 
years whereas there was for children aged 0-14 years (p>0.05).   
 
Only one study sought to investigate families’ motivations concerning place of 
death. Thematic analysis was reported for the positive and negative motivations 
concerning their AYAs’ place of death, end of life care quality of care in hospital 
and home.25  Positive motivations for home death included influence of cultural 
background and personal belief, to let the AYA die in his usual environment close 
to his family and to be close to the AYA even after death. The negative 
motivations for home death included the memory of the dead AYA, personal 
history, to protect the siblings and fear of regretting something.  Positive 
representations of quality of hospital care included the belief that the best care is 
obtained in the hospital and the availability of nursing staff.  The negative 
representations of quality of hospital care included harmful effects of treatment, 
lack of organisation, incompetent nursing staff, lack of humanity in patient care 
and the risk of developing nosocomial disease.25  Only 43% of families were 
informed of the existence of home hospitalisation and only 14% were informed 
about the palliative care mobile unit.  But in reality families said that they did 
not choose place of death as death was sudden, but would have chosen the 
hospital.25  
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2) Experiences and perceptions of AYA 
Only three studies sought the experiences or perspective of the AYA concerning 
issues at the EoL.28,38,39 
Decision Making 
A study by Hinds (2005) investigated the factors influencing EoL care decisions 
and the EoL care preferences of twenty AYAs (10-20 years), who were 
interviewed within 7 days of their participation in one of three types of end-of-
life decisions.28  The characteristics of competent decision making were that they 
were able to identify death as an outcome of their decision and as such 
recognised that they were taking part in making decisions about the end of their 
own life and what this ultimately meant. Hinds concluded that the AYAs realised 
that they were involved in an EoL decision, understood the consequences of this 
decision and were capable of participating in a complex decision process 
involving risks to themselves and others. 
Advanced Care Planning 
A number of documents have been developed to help encourage discussions 
about EoL choices with children and adults with life limiting conditions.  In 
previous studies Wiener and colleagues evaluated “Five Wishes”, an adult 
advanced care planning (ACP) guide that had been used in the AYA population 
and developed an AYA- specific ACP guide called “My Thoughts, My Wishes, My 
Voice” (“MT MW MV”) for AYA’s living with HIV and recurrent cancer43. Further 
research was conducted to assess and compare the usefulness of these two ACP 
guides to see if any improvements could be made.38  Fifty two participants with 
metastatic or recurrent cancer or HIV/infection were included. Participants were 
presented with random pages of the document and asked to rank 25 items on 
several factors including how likely they would be to complete each statement. 
They were provided with two wishes written in similar formats and asked how 
appropriate they felt each was for someone their age.  Qualitative information 
was gathered regarding document preferences regarding wording, layout, 
colour, design and additional content. Fifty-four percent of respondents indicated 
a preference to complete “MT MW MV”, 37% preferred “Five Wishes” and 9% did 
not express a preference. Males were more likely to prefer “Five Wishes “than 
females.  There were no significant differences by diagnosis, race/ethnicity or 
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age group for overall document preference.  Participants preferred “MT MV MV” 
to discuss how they would like to be treated but preferred “Five Wishes “ when 
discussing their comfort.  
 
Lyon et al (2013) conducted a randomised controlled trial of adolescents with 
cancer and their families and engaged in discussions to identify and share 
patients’ preferences for hypothetical care plans if the disease progressed.  The 
approach termed Family –Centred ACP presented hypothetical scenarios to the 
intervention group using three tools i) The Lyon family-centred advanced care 
planning survey, ii) The respecting choices interview and iii) Five Wishes survey. 
The control group participants were given a brochure with information on ACP 
but they did not participate in any discussions using the three tools.  The family-
centred ACP adolescents thought they were significantly better informed about 
EoL decisions than the control group participants.39  
3) Experiences and perceptions of health care professionals and 
family members 
Three papers included the perspective of the healthcare professional28,35,41. One 
of these compared the experiences and perceptions of healthcare professionals, 
parents and AYAs with regard to the factors influencing decision making during 
EoL28.  One paper combined data from across three studies in order to develop 
guidelines for end of life decision making in pediatric oncology.41  Three studies 
were parent reports only29,33,40, one investigated the psychological experiences of 
their AYAs33 , one the physical, psychological and social symptoms29 and what 
makes a good parent.41 
Healthcare professionals  
Decision making 
Hinds (2005) interviewed 14 physicians, 19 parents and 20 AYAs and described 
the factors that influenced EoL decisions, comparing those considered by 
patients, parents and physicians. The factors most frequently mentioned by 
physicians as influencing EoL decisions were the patients’ prognosis and 
comorbid conditions and patient and family preferences.28  
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Interview data from across three studies was analysed to develop guidelines for 
end of life decision making in pediatric oncology.41  Three separate guidelines 
were derived from the three sources, for the healthcare team to use with 
parents, adolescent patients and each other with end of life decision making.  
The agreement across the studies regarding influencing factors were information 
on health and disease status of the patient, curative options having been 
attempted, trusting the healthcare team and feeling support from the health 
care provided.  
Psychosocial needs 
Jones 200635 reported focus group and survey responses from social workers 
regarding their perceptions of the psychosocial needs of pediatric oncology 
patients at the end of life. The needs of children and adolescents were 
compared. The social workers rated 13 of the 20 items in the survey more highly 
for adolescents than for children (p<0.05).  These items were control over 
treatment decisions, choice of where to die, medical information, education 
about the disease and structured conversations.  The 20 items on the survey 
accounted for 57% of the total variance in end of life needs.35  
Parents  
Decision Making 
Hinds 2005, as discussed earlier, interviewed 19 parents of 20 AYAs aged 10-20 
years. The factors most frequently mentioned by parents as influencing EOL 
decisions were ‘continuing to try for a cure for longer’, ‘trusting staff and being 
supported by them’ and ‘deciding as my child prefers’.28  
 
Another study by the same authors 40 asked the question “What makes a good 
parent to my dying child?” Sixty two parents of fifty eight patients with a mean 
age of 11.3 years, who had made one of three EoL decisions during the previous 
72 hours responded to open ended questions about the definition of a good 
parent and how clinicians could help them fulfil this role. The age rage for the 
children and AYAs in this study was from 0.6-21.6 so the results could not be 
delineated between application to children and AYAs. Making informed, unselfish 
decisions in the child/AYAs interest, remaining at the child/AYAs’ side, showing 
that they are cherished, teaching the child/AYA to make good decisions, 
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advocating for the child and promoting the child/AYA’s health were identified as 
important aspects. The parents were also asked to describe the actions from 
staff that would help in their efforts to be a good parent to their child/AYA.  
Fifteen clinician strategies were identified that help parents to be part of making 
these decisions on behalf of a child/AYA the most frequent theme being “all that 
can be done is being done?” appreciating that the family were already receiving 
the best possible care.  
Psychological experiences  
Cataudella and Zelcer 201233 undertook focus groups with bereaved parents to 
categorise parents’ perceptions of their AYAs’ psychological experiences at EoL.  
Three categories were defined: intrapsychic changes, intrapersonal changes and 
post-traumatic growth. The category intrapsychic changes included two sub 
categories, ‘emotional & cognitive changes’ and ‘awareness of impending death’.  
Quotes from the AYAs (10-19) were used to illustrate all of the categories 
developed. For ‘emotional and cognitive changes’ parents reported that many of 
the negative emotions experienced by AYA were attributed to physical changes 
due to disease progression or medication. Cognitive and behavioural sequelae 
were also reported by many parents. For ‘awareness of impending death’, the 
majority of parents thought that their AYAs’ awareness of impending death was 
expressed indirectly through comments, behaviours or gestures. Most parents of 
younger AYAs thought they knew they were going to die.  The category 
intrapersonal changes included the two sub categories ‘being treated as normal 
not sick by others’ and ‘remaining connected with others’.  For being ‘treated as 
normal’ parents shared the importance their AYAs placed on wanting to live 
normally and being treated like normal peers/siblings e.g. attending school and 
participating in school and social activities. Adolescents and Young Adults 
desired to be goal-orientated and have a drive to meet developmental 
milestones more urgently than peers.  For ‘remaining connected with others’, 
most parents reported that children and adolescents in the last month of life 
wanted and looked forward to contact with close ones; relationships developed 
between staff and their child helped facilitate discussions about death and dying. 
The final category was post-traumatic growth and parents commonly described a 
wisdom beyond their child’s years in accepting their situation, findings ways to 
have closure with others and in being worried about others in their own 
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situation. Many parents described how their child showed increased strength in 
coping with aversive treatments/procedures, in accepting developmental 
achievement regressions, in finding meaning from normal things and in 
maintaining hope. Coping strategies were taking an active role in decision 
making and use of humour.  
Symptoms 
Parents of children whose deceased child (mean age of 10.9 years) had received 
palliative care for terminal cancer between 1999 and 2002 (n=32/40) in the 
Netherlands completed questionnaires which sought to examine physical, 
psychological and social symptoms during the palliative phase.29  The mean 
number of physical symptoms per child during the palliative phase was 6.3 (SD 
2.7). There were no statistically significant differences in the number of physical 
and psychological symptoms of the children among the different tumour types 
(p>0.05). The mean number of psychological symptoms of the children varied 
significantly among the different age groups (p<0.005).  Post hoc comparison 
analysis revealed that children older than 12 years suffered from more 
psychological problems than children younger than 7 years. Loss of perspective, 
fear of physical symptoms and death and feelings of guilt were more frequently 
reported in the group above 12 years of age. The mean number of psychological 
symptoms per child during the palliative phase was 3.2 (SD 2.2). Mean number 
of psychological symptoms per couple of parents child during the palliative phase 
was 5.5(SD 1.9). The study also reported that half of the children (50%) did not 
attend school for lessons during the palliative phase. 
4)  Practices/interventions used during EOL care  
One of the goals of palliative care is to control symptoms,44  with pain control a 
major focus of AYA palliative care45. Three studies reported on pain control; one 
was a prospective cohort study27 and the other two used a retrospective 
design.13,37 . One further study investigated control of a variety of physical 
symptoms control through a retrospective review of medical notes.31 
 
The study by Noyes and Irving 200127 reported on the experience at one 
children’s hospital of the use of transdermal fentanyl for pain relief in pediatric 
oncology palliative care.  The authors described transdermal fentanyl as offering 
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a non invasive approach to the management of patients with chronic cancer pain 
with ease of administration and reduction in opioid side effects. Patients were 
eligible for treatment if they had progressive malignant disease, opioid-sensitive 
and stable pain, a minimum daily oral morphine requirement of 30mg/day, 
experiencing side effects from oral opioids or poor compliance with oral 
medication. All four adolescents either had oral opioid side effects or poor oral 
compliance. Duration of previous oral opioid therapy in the four adolescents 
ranged from 4-10 days. The authors noted that older patients were reluctant to 
take immediate release morphine as they did not wish to experience the 
associated drowsiness. One adolescent patient in particular (17y 6m male) was 
reported to have experienced excellent pain relief with fentanyl which impacted 
positively on his mobility. The efficacy of fentanyl was judged as ‘good’ (defined 
as patient only requiring occasional or up to two rescue doses of morphine per 
day) in all four adolescents with no adverse reactions and all four continued with 
fentanyl until death 
 
All pediatric patients aged 0-24 years treated at 38 children’s hospitals located 
throughout the US were included in the study by Orsey et al 2009.13  The 
dataset was extracted using clinical information contained within the Pediatric 
Health Information System and the consisted of 1,466 patients across 33 
hospitals. To aim of the study was to assess variation in opioid prescription 
during the last week among a cohort of pediatric oncology patients who while 
hospitalised. The likelihood of a daily opioid prescription during the hospitalised 
portion of the last week of life varied by three patient-level characteristics: 
patient age, broad category of cancer diagnosis) and length of hospital stay. 
Those aged 10-14 years were most likely to receive daily opioids, those with 
brain tumours significantly less likely to and those who died within 3 days of 
hospitalisation more significantly likely. Opioid prescription during the 
hospitalised portion of the last week of life was found to vary substantially 
among hospitals, even after adjustment for clinical characteristics of the 
patients. In the multilevel multivariate logistic regression model patients 
between the ages of 10 and 19 years were most likely to have daily opioid 
prescription.13 
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Anghelescu et al (2010) examined the impact of epidural and peripheral nerve 
block catheters on pain control in children and young adults with cancer within 
the last 3 months of life over an 18 month period obtained information from pain 
and palliative care databases.37   
 
Seven adolescents were included and separate results were reported for each of 
the participants. A description of the clinical characteristic of each of the patients 
and the interventions for pain management were recorded but no further 
discussion for the young adult population was provided.37 
 
Janssen et al (2000) reported on the experiences of using Boswellic acids in the 
palliative therapy of children and AYAs with progressive or relapsed brain 
tumours over a 4 year period in one hospital in Germany.  The sample included 
8 adolescents (11-18 years) of which 2 had stated subjective relief of symptoms, 
other adolescents had noted a reduction in headache(n=1), an increase in 
muscular strength (n=2), an improvement in hemiparesis (n=2) and cachexia 
(n=1).31 
Discussion 
Setting 
This scoping review included 20 studies published over a fourteen year period 
that investigated or described issues related to end of life care in adolescents 
and yound adults with terminal cancer. The vast majority of available literature 
was based primarily on medical record review of deceased patients, interviews 
with bereaved parents 3-12 years after the AYA’s death, and to a lesser extent 
staff observations. Studies to date of EoL care for AYAs have used retrospective, 
descriptive designs, been conducted in single institutions and have included 
small numbers of patients. With the exception of a very small number of studies 
the perspective of the dying AYA has not been explored. This has also been 
reported for previous reviews for paediatric oncology patients (mainly chidren) 
with cancer at EoL.6,28  A number of papers were excluded from the scoping 
review beacause it was not possible to determine which findings were derived 
from the adolecent age group or because the findings specific to adolescent 
oncology partipants could not be distinguished from those of other non oncology 
related partipcants.   
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Only seven out of the 20 papers dealt solely with AYAs with cancer  The current 
state of research reflects the way that cancer care is ”splintered” beyween 
paediatric and adult oncologists.16  Adolescents and young adults with cancer 
can be treated at either paediatric or adult cancer centres.51   In the UK since the 
1990’s a number ofcomprehensive AYA units have been developed. There are a 
few units in Australia and Europe, however although AYA units are in 
development in North America and Canada no dedicated physical units currently 
exist across the United States.51-52  Albritton and Bleyer 200353 suggest that the 
choice of specialism would vary on a case wise basis, depending on the nature of 
the tumour but that in reality the referrals are often haphazard. The literature 
suggests that referral decisions reflect the judgment of the referring 
physician16,43 familiarity with a specific referral instititution16 as well as patient 
age at diagnosis16,43 and type of cancer.16  In some instances the early 
adolescents are referred to paediatric oncologists and older adolescents seen by 
a variety of specialists depending on their presenting symptoms.45 
EoL Care 
The aim of palliative care for AYA is to enhance the quality life for both the AYA 
and the family and should begin when an AYA is diagnosed with a life-limiting or 
life threatening condition.45  
 
End of life care involves the management of physical and psychological 
symptoms, including relief of suffering from adverse effects of treatment, 
discussion about the place of death, improved quality of life for patients and 
their families and support of family.46-47  Ramphall et al (2011) suggests that in 
paediatric and adult institutions, there is often a lack of awareness or focus on 
many psychosocial issues AYAs face as they would be surrounded by patients 
much older or younger than themselves.16 Adolescents and young adults as 
individuals undergo developmental stages marked by rapid changes in cognitive 
and emotional growth and if psychological and supportive care are to be 
delievered appropriately then these issues must be taken into consideration.47-48 
Such psychosocial issues for AYAs include being able to maintain an active and 
independent life, coping with treatment related side effects and stress, seeking 
and understanding informaton, accepting cancer and maintainng a positive 
attitude.49  A stakeholder group working as part of a recent review conducted by 
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Pritchard et al 2011 identifed the key issues and priorities for AYAs which were: 
i) psychosocial needs of the patient, family and friends and caregivers, ii) 
transition to palliative care-when, how and where, iii) resources required for the 
patient, family and healthcare system and iv) advocacy (Health care 
professionals are required to advocate for the needs of this population and 
increase awareness within hospitals, communities and government).50 
 
For such issues to be considered more research needs to be conducted with 
AYAs themselves.  Trying to obtain information retrospectively from medical 
records to answer such questions has proved to be challenging with very little 
information of what specific services or treatments both physical and 
psychological had been given during the EOL/palliative phase being reported.26 
Place of Death 
The AYA and the family should be able to decide where they would like palliative 
treatment and ultimately place of death to take place, for example home, 
hospital or hospice.45  Even in countries where data were available huge variance 
exists and there is still little rigorous research that documents parents and AYAs 
preference. Appropriate facilities including hospice and home care at EoL vary 
considerably from country to country and needs to be taken into account. 
Advanced Care planning 
An advance care planning document may be appropriate and helpful for 
terminally ill AYA patients with metastatic cancer.43  They give the AYA the 
opportunity to express and capture preferences.38,54-55 and may be an aid in 
initiating EOL discussions between patients, families and clinicians.43   Allowing 
AYA involvement in ACP can help parents and health care agents make informed 
decisions, alleviate distress, avoid regret and could improve the patient’s quality 
of life by taking into consideration their religious, cultural and familial values and 
beliefs.57-58  Such documents exist for the adult population but few resources 
exist to aid AYAs in addressing their changing physical, emotional and social 
needs and wishes around EoL.38  Two studies38-39 explored issues around the use 
of ACP documents for AYAs. As a result of the work by Wiener and colleagues38 a 
new guide has been produced called  “Voicing My Choices: A Planning Guide for 
Adolescents and Young Adults” which incorporated what the AYAs felt was 
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important to them in enabling EOL discussions.59  The approach used by Lyon 
and colleagues39 showed that using a number of Family-centred ACP tools 
combined with hypothetical scenarios resulted in adolescents being better 
informed about EOL options, improved parents’ understanding of the AYAs 
preferences and more agreement between parents and patients about limiting 
treatment.39. Previous work by the same authors regarding EoL decision making 
for adolescents with and without a chronic illness which included AYAs with 
cancer found that across all chronic illnesses AYAs would prefer to discuss their 
wishes  later in the course of their illness with only 16% wanting to do this when 
actually dying.60 
Limitations of the review  
This is a scoping review to present the current range of evidence relating to end 
of life care for adolescents and young adults with cancer. The aim of the review 
was not to provide generalisable conclusions other than that related to the 
current state of knowledge, but to identify the range of evidence available. The 
heterogeneous and descriptive nature of the quantitative studies meant we were 
unable to synthesise the work in a meta-analysis. No qualitative studies were 
located. Studies were limited to those published in English only. 
Conclusion 
The aim of this scoping review was to gather information that sheds light on the 
EoL care provided to AYAs with cancer. We were particularly interested in the 
factors that influence care provision, the experiences and perceptions of AYAs 
their family carers and health professionals and effective practices and 
interventions that support this group. Very few studies investigated interventions 
including pain control, and this may be because very few EoL studies focus 
specifically on the need of AYAs, they are instead included in studies with adults 
and younger children.  
With regard to factors influencing care and experiences and perceptions, only 
one author Hinds28 interviewed AYAs, their parents and health professionals 
involved in their care, who had been faced with actual decisions about their EoL 
care. The need for AYAs to be involved in decision making and care planning has 
been identified through the development of advanced care planning documents 
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aimed specifically at AYAs such as “Voicing My Choices: A Planning Guide for 
Adolescents and Young Adults”43 and this raises questions for future studies, 
whether investigating AYAs wishes through this approach is more feasible than 
when AYAs are at the EoL stage of care. 
Conflicts of interest 
None to declare. 
Implications for practice 
Despite the limited research presented, providing AYAs and their family carers 
with sound information regarding the EoL care options available to them appears 
to be a significant way forward. Where AYAs have made EoL decisions they 
appear to exhibit competent decision making and they should be provided with 
this opportunity through the use of advance care planning documents at a 
suitable stage of their illness. 
 
Implications for research 
Clarification is necessary to enable future studies to be compared and 
synthesised, this should include clear identification of the age group involved, 
their diagnosis and stage of treatment. Future research should focus specifically 
on adolescents and young adults at the end of life and consider both their 
perspective and that of their carers, both families and health care professionals, 
particularly with regard to decision making; this may necessitate using 
hypothetical care planning scenarios. There is an overall lack of in depth 
qualitative studies that explore the needs and requirements of AYAs receiving or 
anticipating to receive end of life care. Whilst retrospective data documenting 
place of death is important to plan future care services, research should also 
focus what factors impact on the choice of home, hospice or hospital care on to 
determine the appropriate place of death and where end of life care should be 
provided on an individual basis that considers culture, the type of care required 
and the needs of both AYAs and their families. Further research needs to be 
undertaken to determine effective interventions and strategies for AYAs to 
address issues such as control of pain and other symptoms at EoL where adult 
and paediatric regimes do not meet the specific needs of the AYA. 
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Appendix 1: Medline Search Strategy 
 
Undertaken 30/08/2012 
 
Search Number Search Terms  Results 
1 exp Adolescent/ 1493907 
2 Adolescen*.mp 1514363 
3 Teen*.mp 18671 
4 exp Young Adult/ 240434 
5 “Young adult*”.mp 281277 
6 “Young person”.mp 511 
7 “young people”.mp 13152 
8 Juvenile*.mp 13152 
9 AYA.mp 98 
10 “young patient*”.mp 16757 
11 “young wom#n”.mp 18721 
12 “young m#n”.mp 12835 
13 Youngster* 1863 
14 Youth.mp 27424 
15 exp Child/ 1452938 
16 Child*.mp 1721558 
17 P?ediatric.mp 172878 
18 1/18 OR 2697023 
19 exp Neoplasms/ 2379037 
20 Cancer*.mp 911589 
21 Malignan*.mp 357236 
22 Neoplasm*.mp 1954182 
23 Leuk?emia 238762 
24 Melanoma.mp 85994 
25 Lymphoma*.mp 168070 
26 Tumo?r.mp 1091468 
27 Carcino*.mp 679368 
28 Oncolog*.mp 74909 
29 Sarcoma*.mp 89517 
30 19/29 OR 2906464 
31 exp Terminal Care/ 38375 
32 exp Palliative Care/ 36852 
33 exp Terminally Ill 5057 
34 exp Hospice Care 4163 
35 EOL.mp 541 
36 (end adj5 life).mp 10804 
37 (terminal adj2 care).mp 19967 
38 (dying adj2 child*).mp 628 
39 (terminal adj2 ill*).mp 1412 
40 31/39 OR 75045 
41 18 AND 30 AND 40 2521 
42 Limit 41 to (English language and 
yr=”1992-Current” and humans 
1584 
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Appendix 2: Screening Tool  
Reference: ____________________________________________   Country_________________ 
First Reviewer____________________  Second Reviewer________________________ 
     Yes   No 
End of Life Care     
 
Adolescents (16-24 years)       exclude  
 
  Included with children    mean (years)  range (years)   
  Included with adults    mean (years)  range (years) 
  Included with children & adults  mean (years)  range (years) 
Separate results reported for TYA     exclude 
 
Research        exclude 
Review article     
 
Cancer          exclude 
 Included with other conditions 
__________________________________________________________________________________ 
If included then  
Research Design 
Quantitative     Specify…………………………………………………………………….. 
Qualitative     Specify…………………………………………………………………….. 
Participants 
Adolescents (16-24 years)   Mean (years)…………. Range (years)…………………. 
Parents 
Siblings 
Health Professionals     Specify…………………………………………………………………… 
Type of cancer    Specify……………………………………………………………………………….
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Appendix 3: Data Extraction Tool : MAStARI 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
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Appendix 4: Data extraction tool: QARI 
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Appendix 5: Included studies table 
Author, Year of publication 
Country, Source of data, Aims  
Design & Methods Population Age  
Noyes and Irving 201127 
Australia 
 
Royal Children’s Hospital – oncology 
Unit Queensland and Northern New 
South Wales 
 
To report on the experience at one 
children’s hospital in the use of 
transdermal fentanyl for pain relief in 
pediatric oncology palliative care 
Prospective cohort 
 
Time frame EOL 
Treatment time  
Palliative treatment to 
death  
6 hours to 22 days  
 
 
Children (n=9) and adolescents 
(n=4) in receipt of palliative care 
for progressive malignant disease 
between March 1997 and 
December 1999  
 
Cancer Diagnosis 
Leukaemia (n=1) 
Solid tumours (n=3) 
 
Treatment 
Transdermal fentanyl 
 
 
Age at treatment (years) 
3.9-18.7 years  
Separate results were provided 
for all participants 
 
13 years 4months 
16 years 4 months 
18 years 7 months 
17 years 6 months 
 
Orsey et al 200913 
USA 
 
Pediatric Health Information System 
database for 38 children’s hospitals 
located throughout the USA 
 
To assess variation in opioid 
prescription during the last week 
among a cohort of pediatric oncology 
patients who while hospitalised 
 
Retrospective cohort  
 
Retrospective review of 
medical notes 1 week 
pre death  
 
Time frame EOL 
Opioid medications 
during last week of life   
 
Children and adolescents treated 
at 33 hospitals between 2001 and 
2005  
 
Cancer Diagnosis 
Leukaemia & Lymphoma (n=734) 
Brain (n=235) 
Bone and soft tissue (n=107) 
Other (n=350) 
 
Treatment 
Opioids 
 
 
Age at treatment (years) 
0-24 years (n=1466)  
 
10-14 years (n=322) 
15-19 years (n=340) 
20-24 years (n=60) 
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Janssen et al 200031 
Germany 
 
Children’s Hospitals of Bonn, 
Dusseldorf and Wuppertal  
 
To report experiences with Boswellic 
acids in the palliative therapy of 
children with progressive or relapsed 
brain tumours 
Retrospective cohort 
 
Retrospective review of 
medical notes 
 
Time frame EOL 
Median treatment time 
9 months 
Range 1-26 months 
Children and adolescents treated 
at four children’s hospitals 
between 1995 and 1998 
 
Cancer Diagnosis 
Brain tumours (100%) 
 
Treatment 
Boswellic acids  
 
 
Age at death (years) 
0.5-18 years (n=19) 
 
11-13 years  (n=5) 
14-18 years (n=3) 
 
 
Hinds et al 200141 
USA 
 
To use three sources to develop 
guidelines for end of life decision 
making in pediatric oncology 
 
 
Study 1 
Retrospective descriptive  
 
Open-ended interview 
questions via telephone 
& a 15 item 
questionnaire for 
parents. 
 
Face to face interviews 
with health 
professionals. 
 
Study 2 
Prospective descriptive 
study  
Interviews 
 
Study 3 
Prospective descriptive, 
cross sectional, three 
site international 
feasibility study 
 
Study1 
Parents (n=39/83) of patients 
(n=37) at a pediatric oncology 
institution who had died in the 
previous 6-24 months and 
corresponding healthcare 
professionals (n=37) 
 
Study 2 
Parents (n=52) from 51 families, 
and one 18 years old patient 
making her own decision and 
adolescents (n=9/15 physicians 
(n=22/24)  
 
Study 3 
Parents (n=43) who had made an 
end of life decision within the past 
few hours to 3 weeks.  
 
Study 1 
Age at death (years) Hinds et al 
(1997)  
Mean 13.27 (SD 5.10) 
Range 1.7-23.8 years 
 
Study 2 
Age at treatment (years) 
15-18 years  
 
Study 3 
Age at death (years) 
Not specified 
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Hinds et al 200528 
Australia, USA 
 
St Jude Children’s Research Hospital 
in Memphis 
Sydney Children’s Hospital In Sydney 
 
To identify the preferences of 
children and adolescents with 
advanced cancer about their end of 
life care and the factors that 
influenced their decisions 
Descriptive 
Cross sectional survey  
 
Interviews 
 
Time frame EOL 
End of life decision 
making within the 
previous 7 days  
Children and adolescents from one 
pediatric oncology centre (n=20) 
and their parents and physicians  
 
Cancer diagnosis 
Refractory slid tumour (n=12) 
Brain tumour (n=4) 
Leukemia (n=4) 
Age at time of study (years) 
10-20 years  
Mean 17 years and 4 months  
 
 
Hinds et al 200940 
USA 
 
St Jude Children’s Research Hospital 
in Memphis 
 
To explicate the meaning of being a 
good parent to a child with incurable 
cancer  
 
 
Descriptive  
Cross sectional survey 
 
Interviews  
 
Time frame EOL 
End of life decision 
making within previous 
72 hours 
Parents of patients had made a 
non curative treatment decision 
during the previous 72 hours. 62 
parents of 58 patients 
participated. 
 
Cancer diagnosis 
Solid tumour (n=30) 
Brain tumour (n=21) 
Leukemia (n=7) 
 
  
Age at time of study (years) 
Mean age 11.3 (SD 6.2) 
Median 11.4 
Range 0.6-21.6 years 
 
 
Surkan et al 200630 
Sweden 
 
Swedish Cause of Death Register 
 
To assess the relationship between 
place of the child’s end of life care in 
relation to several possible predictors 
related to parental; awareness of the 
child’s impending death.  
 
To examine symptom relief relative 
Retrospective 
descriptive 
 
Questionnaire 
(365 items) 
 
Time frame EoL  
EoL defined as last 
month of life and parents 
sent 
Parents of children (n=254) and 
adolescents (n=195) (diagnosed 
with cancer before 17 years and 
dying before 24 years between 
1992 and 1997  
 
Cancer diagnosis 
Brain tumour (n=150) 
Leukemia or lymphoma (n=141) 
Sarcoma or neuroblastoma 
(n=87) 
Other malignant disease (n=41) 
Age at diagnosis (years) 
9-15 years (n=97) 
16-24 years (n=98) 
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to place of end of life care EoL home 
care and parental awareness of 
impending death 
 
Theunissen et al 200729Netherlands 
 
Department of Pediatric 
Haematology/Oncology of the 
Radboud University Nijmegen 
Medical Centre  
 
To examine physical, psychological 
and social symptoms of children with 
cancer and their parents during the 
palliative phase 
Retrospective 
descriptive 
 
Questionnaires 
 
Time frame EoL 
Palliative care defined as 
shift in the goal from 
cure to palliation 
Parents of children whose 
deceased child had received 
palliative care for terminal cancer  
between 1999 and 2002 
(n=32/40)  
 
Cancer Diagnosis 
Leukemia / MDS (n=10) 
Brian tumour (n=10) 
Other solid tumours (n=12) 
  
Age at death (years) 
Mean 10.9 (SD 4.9) 
Cataudella and Zelcer 201233 
Canada 
 
Patient tumour registry for south 
western Ontario 
 
To explore the psychological 
experiences of children with brain 
tumours at the end of life 
 
Retrospective 
descriptive  
 
Focus groups of 
bereaved parents  
 
Time Frame EOL 
Mean = 5 years 
Median 5.5 years 
Parents of children (n=24) who 
have died from a brain tumour 
from 1996-2006  
 
Cancer Diagnosis 
Brain tumours (100%) 
 
Age at death 
1-5 years  (n=3) 
8-11 years (n=3) 
12-19 years (n=11) 
Higginson and Thompson 200320 
United Kingdom 
 
Death registrations in England and 
Wales  
 
To investigate the associations 
between place of death and potential 
explanatory variables for children 
and young people who die from 
cancer  
Retrospective 
descriptive 
 
Retrospective data 
analysis for all cancer 
deaths from death 
registrations in England 
& Wales 1995-1999 
Children, adolescents & young 
adults who died from cancer 
1995-1999 
 
Cancer Diagnosis 
Brain cancer (n=176) 
Leukaemia & Lymphoma (n=379) 
Bone and soft tissue  (n=259) 
Endocrine glands other than 
thyroid (n=20) 
Hodgkin’s disease (n=70) 
Kidney and other urinary cancer 
Age at death (years) 
0-15 years n=1725 
of which 11-15 years n=525 
 
16-24 years n= 1472 
of which 16-20 years n=712 
of which 21-24 years n=760 
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(n=10) 
Melanoma (n=51) 
Female genital organs (n=52) 
Testis (n=36) 
Other (n=419) 
 
Shah et al 201132 
United Kingdom  
 
National Registry of Childhood 
Tumours for England  
 
To describe patterns of care and to 
evaluate factors influencing place of 
death for children who died after a 
diagnosis of cancer in England during 
1999-2006 
 
Retrospective 
descriptive  
 
Retrospective data 
analysis for all 
registrations of children 
who were diagnosed with 
cancer and died during 
1999-2006 
 
Children (n=1864) under 15 years 
who were diagnosed with cancer 
and who died under the age of 20 
years 
 
Cancer Diagnosis 
Brain and spinal tumours (n=640) 
All leukaemias (n=456) 
ALL (n=236) 
AML (n=140) 
Soft tissue sarcomas (n=180) 
Sympathetic nervous system 
tumours (n=175) 
Bone tumours (n=135) 
Lymphomas (n=112) 
Renal tumours (n=71) 
Hepatic tumours (n=38) 
Epithelial tumours (n=37) 
Germ call and gonadal tumours 
(n=13) 
Other and unspecified malignant 
neoplasm (n=7)  
 
 
 
 
 
Age at death (years) 
10-14 years (n=503) 
15-19 years (n=179) 
NCIN 201134 
To determine place of death for 
children , teenagers and young 
Retrospective 
descriptive 
 
Children, teenagers and young 
adults who died from cancer 
2000-2009 
Age at death (years) 
Under 15 years (n=1,454) 
15 -24 years (n=1,767) 
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adults with Cancer in England 
UK  
 
Retrospective data 
analysis for all cancer 
deaths from the National 
Cancer Data Repository 
in England (excluding 
London and South East 
England) 2000-2009 
Anghelescu et al 201037 
USA 
 
St Jude Children’s Research Hospital 
in Memphis 
 
To examine the impact of epidural 
and peripheral nerve block catheters 
on pain control  in children and 
young adults with cancer within the 
last 3 months of life 
 
Retrospective cohort 
 
Survey of pain and 
palliative care databases 
 
Time frame EOL 
3 months preceding 
death 
Children and young adults who 
had epidural and/or peripheral 
nerve block catheters for pain 
control at the end of life between 
May 2008 and October 2009 
 
Cancer diagnosis 
Solid tumours (n=9) 
Lymphoma (n=1) 
 
Treatment 
Epidural and/or peripheral nerve 
block catheters for pain control 
 
  
Age at death (years) 
4.4-21.3 years (n=10) 
13.2-21.3 years (n=7) 
 
 
Separate results were reported 
for each participant.  
 
Pain Control 
Description of the clinical 
characteristic of each of the 
patients and the interventions for 
pain management. 
 
Place of death  
Death location (Preferred: home 
(n=6), hospital (n=1), Actual: 
home (n=6), hospital (n-1) 
 
Four adolescents died with a 
catheter in place, two at home. 
 
Bell et al 201042 
USA 
 
Midwestern tertiary care centre  
 
To explore the EoL experiences of 
adolescents dying from cancer, 
Retrospective cohort  
 
Data obtained from 
charts, medical records, 
outpatient clinic nursing 
phone logs, and social 
work files on each 
Adolescents between 10-21 years 
treated from 1982 to 2004 and 
who subsequently died between 
2000 and 2005 
 
Cancer Diagnosis 
Leukaemia & Lymphoma (n=40) 
Age at diagnosis 
0.53-19 years  
Mean 11.2 (SD 4.5) years)  
 
Age at death (years) 
10-21 years (n=103) 
Mean 14.4 (SD 2.9) years  
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including place of death, medications 
used at EOL, and initiation of EOL 
discussions between health 
professionals and adolescents during 
early, middle and late adolescence 
and their families 
patient 
 
Time frame EOL 
EOL defined as time from 
initial EOL discussion to 
death and categorised as  
0-14 days 
15-30 days 
31-60 days 
61-179 days 
180-880 days   
But numbers of 
adolescents in each 
category not reported 
 
Solid tumour (n=39) 
CNS / brain tumour (n=10) 
 
 
 
Early adolescence 
10-13 early (n=42) 
 
Middle adolescence  
14-17 years (n=44) 
 
Late adolescence 
18-21 years (n=17) 
De Graves and Aranda 201226 
Australia 
 
Single tertiary paediatric centre 
 
To explore the extent in which the 
shift from cure to palliation is 
reflected in the child’s medical record 
Retrospective cohort 
 
Medical record review 
 
In depth content analysis 
 
Time frame EOL 
Period of EOL care not 
defined data was 
collected from medical 
notes from diagnosis to 
death 
Children (n=18: adolescents n=9) 
with cancer who died from disease 
progression during 1999  
 
Cancer Diagnosis 
Myoepithelial tumour (n=1) 
Ewing’s sarcoma (n=1) 
Acute lymphoid lymphoma (n=2) 
Burkitt’s lymphoma (n=1) 
Osteosarcoma (n=1) 
Brainstem glioma (n=1) 
Cerebral glioblastoma (n=1) 
Primitive neuro ectodermal 
tumour (n=1) 
Medulloblastoma (n=1) 
 
Age at diagnosis  
Mean age 7.5 years 
Range 0.7 - 16 
10-13 years (n=5) 
14-16 years(n=4) 
 
Age at death 
Mean 10 years  
Range 3-17 
10-13 years (n=3)  
14-17 years (n=6) 
 
Cohen-Gogo et al 20125 
France 
 
Pediatric and Adolescent Oncology 
Department at the Institut Gustave 
Retrospective cohort 
 
Medical and nurses chart 
analysis 
 
Patients over the age of 13 years 
who had consulted at least once 
and died between January 2007 
and December 2008 (n=45)  
 
Age at diagnosis (years) 
Median 15.9  
Range 5.2-24.2 years 
 
Age at death (years) 
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Roussy  
 
To provide broad baseline 
information about clinical history and 
patterns of EOL care of AYA in one 
adolescent unit  
 
Time frame 
Clinical history of cancer 
and cancer treatment, 
patterns of physical 
symptoms collected 
during last week of life 
 
Time Frame EOL 
Last month of life 
 
Cancer Diagnosis 
Sarcomas (n=19) 
Brain tumours (n=16) 
Leukaemia & Lymphoma (n=3) 
Other solid tumours (n=7) 
 
Median 18.8 years  
Range 14.2-26.2 years 
Montel et al 200925 
France 
 
Paediatric Oncology Department of a 
regional cancer centre  
 
To study the place of death of 
adolescents and young adults treated 
within Institute Curie (Cancer 
Centre) and to identity some of the 
determinants of the choice of place 
of death 
Retrospective cohort  
 
Semi structured 
interviews  
 
Socio-demographic data 
also extracted from 
medical notes  
 
Time frame EOL  
not defined 
Parents and/or partners of  
adolescents/young adults aged 
between 15-25 who died between 
2000-2003 (n=21) 
 
Cancer Diagnosis 
Ewing sarcoma (n=7) 
Oestosarcoma (n= 6) 
Rhadomysacroma (n=3) 
Chondosracoma (n=1) 
Neurobastoma (n=1) 
Malignant temporal tumour (n=1) 
Neuroectodermal tumour (n=1) 
Pulmonary adenocarcinoma (n=1) 
 
Age at death (years) 
19 years + 5 years 
 
Jones 200635 
USA 
 
Social workers perspectives on the 
needs of children with cancer and 
their families at the end of life 
Descriptive  
Cross sectional survey  
 
Questionnaire with open 
ended questions  
 
Time frame EOL 
Not defined 
Paediatric oncology social workers 
(n=131)  
 
 
 
Psychosocial needs of children 
(0-14 years) and adolescents 
(15-21 years) 
 
Lyon et al 201339 
USA 
 
Randomised 
controlled trial (RCT) 
 
Adolescents aged 14-21 years 
with cancer (n=30) their 
surrogates or families enrolled 
Age at time of study  
Mean 16.3 / Mode 14 years  
Range 14-21 years 
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Pediatric oncology program 
 
To examine the efficacy of family 
centred advanced care planning 
(ACP) 
2 group RCT in a 
paediatric  oncology 
program 
 
At baseline all 
participants given ACP 
brochure 
 
Intervention (I) - 3 
sessions of approx. 60 
mins weekly to go 
through ACP document 
(n=17). 
 
Control (C)- Did not 
receive 3 session-
facilitated   conversation 
but standard care 
(n=13) 
 
Completed the same  
assessments at the same 
5 time points 
 
Time Frame EOL 
Not defined  
between January  2011 and March 
2012  
 
Cancer Diagnosis 
Leukaemias (n=14) 
Lymphoma (n=2) 
Solid tumour (n=6) 
Brain tumour (n=8) 
 
 
 
Wiener et al 201238 
USA 
 
Pediatric Oncology Branch from the 
National Cancer Institute  
 
To assess and compare the 
usefulness, helpfulness and stress 
associated with receiving a 
previously adapted ACP guide  My 
Thoughts, my Wishes, My Voice 
Descriptive  
Cross sectional survey  
 
ACP tool development 
A 5-point Likert-type 
scale evaluating the 
degree of helpfulness 
and stressfulness of each 
wish contained within a 
previously adapted 
advance care planning 
Adolescents aged 16-28 years 
living with recurrent or metastatic 
cancer (n=26) or HIV (n=26) 
between March 2008 – August 
2011 
 
Cancer Diagnosis 
Recurrent or metastatic cancer 
(n=26) 
 
 
Age at time of study 
Mean 20.3 years  
Range 16-28 years  
 
49 
 
(MTMWMV) in comparisons with the 
widely used adult document Five 
Wishes by AYS’s living with a serious 
illness  
guide, (MTMWMV) in 
comparison with the 
widely used document 
Five Wishes by 
adolescents and young 
adults living with a 
serious illness.  
 
Time Frame EOL 
Not defined 
Key: AYA – Adolescents and young adults, CCLG – Children’s Cancer and Leukaemia Group  
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Appendix 6: Reasons for excluding studies  
Reasons for exclusion n 
Children included with adolescents -data not presented separately 70 
Adolescents included with adults - data not presented separately 47 
Data related to children only, not adolescents 24 
Adolescents included with children and adults-data not presented separately 14 
Not EoL 38 
Not research 23 
Not cancer 6 
Unavailable 4 
Adults 10 
Adolescent carers 2 
Individual Case studies 28 
Same study published multiple times 14 
Review Paper 16 
Total 296 
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